person · Reporting owner
Johnson Lloyd Emerson
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APOGEE ENTERPRISES, INC.APOG · Entity 5131 | Director | March 31, 2026 | April 01, 2026 |
| BEAZER HOMES USA INCBZH · Entity 5036 | Director | November 17, 2025 | November 18, 2025 |
| HAEMONETICS CORPHAE · Entity 3953 | Director | July 24, 2026 | July 28, 2026 |
| VSE CORPVSEC · Entity 3833 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APOGEE ENTERPRISES, INC.
Report date March 31, 2026 · Filed April 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,264 |
Reported balance
After 2026-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 153 · Balance 19,264 F1: Settled 1-for-1. F2: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F3: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Settled 1-for-1.
F2: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan.
F3: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.
BEAZER HOMES USA INC
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,829 |
Reported balance
After 2025-11-17 transaction · row 1
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 7,199 · Balance 41,829 F1: Restricted stock award scheduled to vest on the first anniversary of grant date. |
| Common StockSEC Table I · non-derivative | IndirectJuanita Johnson Trust | 45,000 |
Reported balance
Holding disclosure · report date 2025-11-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 45,000 F2: Shares held through The Juanita Johnson Trust |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award scheduled to vest on the first anniversary of grant date.
F2: Shares held through The Juanita Johnson Trust
HAEMONETICS CORP
Report date July 24, 2026 · Filed July 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,471 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 2,538 · Balance 15,471 F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
VSE CORP
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.05SEC Table I · non-derivative | Direct | 7,451 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 745 · Balance 7,451 F1: Represents shares issued as part of the annual compensation for service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued as part of the annual compensation for service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 28, 2026 20:56 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000313143-26-000105 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,471 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 21:13 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 153 | $33.54 | $5,131.62 |
DisclosureSEC source: 0001708823-26-000006 · wk-form4_1775078023.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,264 Underlying: Common Stock · 153 shares Expires not disclosed F1 · derivative.exercise_price: Settled 1-for-1. F2 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F3 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F3 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 18:12 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | Exercise / conversionDeferred Restricted Stock Units · Derivative | 2,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001708823-26-000004 · wk-form4_1767723153.xml · derivative · entry 2 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,111 Underlying: Common Stock · 2,883 shares Expires 2026-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Settled -1 for -1. F1 · price: The deferred restricted stock units were settled in shares of common stock in accordance with the election of the reporting person as specified in the Plan. F3 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 18:12 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | Exercise / conversionCommon Stock | 2,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001708823-26-000004 · wk-form4_1767723153.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The deferred restricted stock units were settled in shares of common stock in accordance with the election of the reporting person as specified in the Plan. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:44 UTC | VSE CORP VSEC · Entity 3833 | GrantCommon Stock, par value $.05 | 745 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004655 · ownership.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,451 F1 · shares: Represents shares issued as part of the annual compensation for service as a director. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:25 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 0 | $36.41 | $0.00 |
DisclosureSEC source: 0001708823-26-000002 · wk-form4_1767648350.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,994 Underlying: Common Stock · 157 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 23:26 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 7,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001708823-25-000006 · wk-form4_1763508405.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,829 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 129 | $43.57 | $5,620.53 |
DisclosureSEC source: 0001628280-25-043714 · wk-form4_1759436151.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,837 Underlying: Common Stock · 129 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 20:28 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,693 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-019595 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,933 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 15:50 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 118 | $40.60 | $4,790.80 |
DisclosureSEC source: 0000006845-25-000130 · wk-form4_1751471400.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,708 Underlying: Common Stock · 118 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 16:11 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0000006845-25-000120 · wk-form4_1751040665.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,590 Underlying: Common Stock · 2,954 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F3 · balance_after: Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 15:26 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 105 | $46.33 | $4,864.65 |
DisclosureSEC source: 0000006845-25-000035 · wk-form4_1743607588.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,636 Underlying: Common Stock · 105 shares Expires not disclosed F1 · derivative.exercise_price: Settled 1-for-1. F2 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F3 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F3 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 17:14 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | PurchaseCommon Stock | 22,500 | $22.23 | $500,235.75 |
DisclosureSEC source: 0000915840-25-000036 · wk-form4_1739294042.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Juanita Johnson Trust Disclosed balance after: 45,000 F1 · price: The price is the weighted average price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $21.95 to $22.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: Shares held through the Juanita Johnson Trust Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 01:13 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | PurchaseCommon Stock | 22,500 | $22.68 | $510,378.75 |
DisclosureSEC source: 0000915840-25-000034 · wk-form4_1739236422.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Juanita Johnson Trust Disclosed balance after: 22,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.2518 to $22.80, inclusive. The reporting person undertakes to provide to Beazer Homes USA, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held through the Juanita Johnson Trust Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:16 UTC | VSE CORP VSEC · Entity 3833 | GrantCommon Stock, par value $.05 | 1,454 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002112 · ownership.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,706 F1 · shares: Represents shares issued as part of the annual compensation for service as a director. Read SEC document |
| January 02, 2025 Filed Feb 26, 2025 18:26 UTC Amendment | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | Exercise / conversionDeferred Restricted Stock Units · Derivative | 2,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000006845-25-000031 · wk-form4a_1740594382.xml · derivative · entry 3 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,531 Underlying: Common Stock · 2,811 shares Expires 2025-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Settled 1-for-1 F1 · price: The deferred restricted stock units were settled in shares of common stock in accordance with the election of the reporting person as specified in the Plan. F4 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| January 02, 2025 Filed Feb 26, 2025 18:26 UTC Amendment | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | Exercise / conversionCommon Stock | 2,811 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000006845-25-000031 · wk-form4a_1740594382.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The deferred restricted stock units were settled in shares of common stock in accordance with the election of the reporting person as specified in the Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 17:44 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 0 | $71.41 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006845-25-000004 · wk-form4_1735926254.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,342 Underlying: Common Stock · 75 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| December 31, 2024 Filed Feb 26, 2025 18:26 UTC Amendment | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 75 | $71.41 | $5,355.75 |
DisclosureSEC source: 0000006845-25-000031 · wk-form4a_1740594382.xml · derivative · entry 2 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,342 Underlying: Common Stock · 75 shares Expires not disclosed F2 · derivative.exercise_price: Settled 1-for-1 F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F4 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F4 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:44 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 5,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-24-000104 · wk-form4_1732052682.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,630 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of the grant date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:11 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 0 | $70.02 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006845-24-000242 · wk-form4_1727899908.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,267 Underlying: Common Stock · 74 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:26 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021036 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,240 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 18:45 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 0 | $62.84 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006845-24-000211 · wk-form4_1719859515.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,193 Underlying: Common Stock · 78 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:54 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 1,893 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006845-24-000190 · wk-form4_1719003267.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,115 Underlying: Common Stock · 1,893 shares Expires not disclosed F1 · security: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F1 · derivative.exercise_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F3 · balance_after: Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:22 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | SaleCommon Stock | 24,000 | $63.13 | $1,515,120.00 |
DisclosureSEC source: 0000006845-24-000128 · wk-form4_1715026920.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Trust Disclosed balance after: 260 F1 · price: The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $62.39 to $63.88. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 20:42 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 81 | $59.20 Strike: $0.00 | $4,795.20 |
DisclosureSEC source: 0000006845-24-000041 · wk-form4_1712004121.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,222 Underlying: Common Stock · 81 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:55 UTC | VSE CORP VSEC · Entity 3833 | GrantCommon Stock, par value $.05 | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-002021 · ownership.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,252 F1 · shares: Represents shares issued as part of the annual compensation for service as a director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 19:48 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 83 | $53.41 Strike: $0.00 | $4,433.03 |
DisclosureSEC source: 0000006845-24-000012 · wk-form4_1704311276.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,141 Underlying: Common Stock · 83 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 02:38 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 6,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-23-000081 · wk-form4_1700620675.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,579 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 16:53 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 98 | $47.08 Strike: $0.00 | $4,613.84 |
DisclosureSEC source: 0001209191-23-051324 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,058 Underlying: Common Stock · 98 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:32 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,226 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022201 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,033 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:52 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 83 | $47.47 Strike: $0.00 | $3,940.01 |
DisclosureSEC source: 0001209191-23-040866 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,960 Underlying: Common Stock · 83 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 23:22 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 2,409 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039173 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,877 Underlying: Common Stock · 2,409 shares Expires not disclosed F1 · security: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F1 · derivative.exercise_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F3 · balance_after: Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 18:17 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 91 | $43.25 Strike: $0.00 | $3,935.75 |
DisclosureSEC source: 0001209191-23-022070 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,468 Underlying: Common Stock · 91 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:16 UTC | VSE CORP VSEC · Entity 3833 | GrantCommon Stock, par value $.05 | 2,146 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000596 · doc4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,515 F1 · shares: Represents shares issued as part of the annual compensation for service as a director. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 20:07 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 81 | $44.46 Strike: $0.00 | $3,601.26 |
DisclosureSEC source: 0001209191-23-000705 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,377 Underlying: Common Stock · 81 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. Read SEC document |
| November 14, 2022 Filed Nov 17, 2022 00:04 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 14,181 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-22-000058 · wf-form4_166864344226228.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,555 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 19:23 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 93 | $38.22 Strike: $0.00 | $3,554.46 |
DisclosureSEC source: 0001209191-22-052139 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,296 Underlying: Common Stock · 93 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 21:33 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-020700 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,807 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 23:14 UTC | VSE CORP VSEC · Entity 3833 | GrantCommon Stock, par value $.05 | 1,369 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-026978 · doc4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,369 F1 · shares: Represents shares issued as part of the annual compensation for service as a director. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:31 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 74 | $39.22 Strike: $0.00 | $2,902.28 |
DisclosureSEC source: 0001209191-22-040710 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,203 Underlying: Common Stock · 74 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Incentive Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 17:36 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 2,773 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039152 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,129 Underlying: Common Stock · 2,773 shares Expires not disclosed F1 · security: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F1 · derivative.exercise_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were awarded under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. F3 · balance_after: Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 18:06 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 62 | $47.46 Strike: $0.00 | $2,942.52 |
DisclosureSEC source: 0001209191-22-022215 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,356 Underlying: Common Stock · 62 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:14 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 55 | $48.15 Strike: $0.00 | $2,648.25 |
DisclosureSEC source: 0001209191-22-000693 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,294 Underlying: Common Stock · 55 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| November 12, 2021 Filed Nov 17, 2021 00:29 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 7,679 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-21-000070 · wf-form4_163710892629173.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,374 F1 · shares: Restricted stock award scheduled to vest on the first anniversary of grant date. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 18:26 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 68 | $37.76 Strike: $0.00 | $2,567.68 |
DisclosureSEC source: 0001209191-21-058826 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,239 Underlying: Common Stock · 68 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1 F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 22:54 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 3,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-023386 · form4.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,077 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 18:15 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantDeferred Restricted Stock Units · Derivative | 51 | $40.73 Strike: $0.00 | $2,077.23 |
DisclosureSEC source: 0001209191-21-044297 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,171 Underlying: Common Stock · 51 shares Expires not disclosed F1 · security: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.exercise_price: Settled 1-for-1. F3 · kind: Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. F1 · derivative.exercise_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F1 · derivative.expiration_date: The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 21:16 UTC | BEAZER HOMES USA INC BZH · Entity 5036 | GrantCommon Stock | 1,695 | $0.00 | $0.00 |
DisclosureSEC source: 0000915840-21-000040 · wf-form4_162500136472256.xml · nonDerivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · shares: Restricted stock award pursuant to the Company's 2014 Long-Term Incentive Plan. Award is scheduled to vest in full on the first anniversary of the grant date. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 15:46 UTC | APOGEE ENTERPRISES, INC. APOG · Entity 5131 | GrantRestricted Stock Units · Derivative | 2,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043230 · doc4.xml · derivative · entry 1 Johnson Lloyd Emerson · CIK 0001708823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,721 Underlying: Common Stock · 2,721 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Apogee Enterprises, Inc. common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest over a three year vesting period with one-third of the units vesting on each anniversary of the award. Vested shares will be delivered to the reporting person following the date the reporting person no longer serves as a director of Apogee Enterprises, Inc. in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F2 · derivative.expiration_date: The Restricted Stock Units vest over a three year vesting period with one-third of the units vesting on each anniversary of the award. Vested shares will be delivered to the reporting person following the date the reporting person no longer serves as a director of Apogee Enterprises, Inc. in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan. F3 · balance_after: Awarded under the 2019 Non-Employee Director Stock Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.